BioLargo Inc (OTCQB:BLGO) has announced preliminary 2022 financial results, revealing full-year revenue that more than doubled the company’s 2021 figure.
The full-service environmental engineering company posted top-line revenue of more than $5.75 million, over 125% higher than its 2021 revenue.
"Our current success reflects the significance of our expanding portfolio of sustainable technologies and products,” CEO Dennis Calvert said in a statement. “We believe our revenue growth will continue in 2023 as we focus on our PFAS removal water treatment system the AEC, the pet-odor product Pooph, and major engineering projects. This commercial success also validates our business model and raises the profile for our entire portfolio."
READ: BioLargo drops pet odor control product Pooph into Walmart stores across the US
He continued: “In our water technology business, we are finalizing our national network of channel partners and manufacturer's representatives for our PFAS and water treatment technologies, with nine signed agreements covering most of the United States and Canada.
“Our medical subsidiary also has secured agreements that mobilize over 25 manufacturer's representatives, and is in negotiations with a number of major channel partners that serve specific markets within the healthcare industry.”
Westminster, California-based BioLargo is a developer of sustainable cleantech technologies and full-service environmental engineering company.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel